Activated NKT cells increase dendritic cell migration and enhance CD8+ T cell responses in the skin

European Journal of Immunology

Volumn 36, Issue 9, 2006, Pages 2494-2503

  Gorbachev, Anton V ^a   Fairchild, Robert L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Dendritic cells; NKT cells; T cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD8 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; FEMALE; GRAFT VERSUS HOST REACTION; IMMUNOMODULATION; LYMPHATIC DRAINAGE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; SKIN; SKIN TUMOR; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748876364     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636075     Document Type: Article

References (43)

1. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. and Baxter, A. G., NKT cells: facts, functions and fallacies. Immunol. Today 2000. 21: 573-583.
2. Kinjo, Y., Wu, D., Kim, G., Xing, G. W., Poles, M. A., Ho, D. D., Tsuji, M. et al., Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005. 434: 520-525.
3. Mattner, J., Debord, K. L., Ismail, N., Goff, R. D., Cantu, C. 3rd, Zhou, D., Saint-Mezard, P. et al., Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005. 434: 525-529.
4. Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C. R., Koezuka, Y. and Kronenberg, M., Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000. 192: 741-754.
5. Burdin, N., Brossay, L. and Kronenberg, M., Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol 1999. 29: 2014-2025.
6. Kawakami, K., Kinjo, Y., Yara, S., Koguchi, Y., Uezu, K., Nakayama, T., Taniguchi, M. and Saito, A., Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun. 2001. 69: 213-220.
7. Kitamura, H., Iwakabe, K., Yahata, T., Nishimura, S., Ohta, A., Ohmi, Y., Sato, M. et al., The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 1999. 189: 1121-1128.
8. Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. and Steinman, R. M., Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 2003. 198: 267-279.
9. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H. et al., CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629.
10. +NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 1999. 163: 93-101.
11. Hong, S., Wilson, M. T., Serizawa, L, Wu, L., Singh, N., Naidenko, O. V., Miura, T. et al., The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 1052-1056.
12. Jahng, A. W., Maricic, I., Pedersen, B., Burdin, N., Naidenko, O., Kronenberg, M., Koezuka, Y. and Kumar, V., Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 2001. 194: 1789-1799.
13. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M. et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001. 7: 1057-1062.
14. Cumberbatch, M., Dearman, R. J. and Kimber, I., Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology 1997. 92: 388-395.
15. Eisen, H. N., Orris, L. and Belman, S., Elicitation of delayed allergic skin reactions with haptens; the dependence of elicitation on hapten combination with protein. J. Exp. Med. 1952. 95: 473-487.
16. Kalish, R. S. and Johnson, K. L., Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol. J. Immunol. 1990. 145: 3706-3713.
17. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 1990. 144: 4121-4128.
18. + T cells. J. Exp. Med. 1996. 183: 1001-1012.
19. Zeng, D., Lewis, D., Dejbakhsh-Jones, S., Lan, F., Garcia-Ojeda, M., Sibley, R. and Strober, S., Bone marrow NK1.1 (-) and NK1.1 (+) T cells reciprocally regulate acute graft versus host disease. J. Exp. Med. 1999. 189: 1073-1081.
20. Oh, K., Kim, S., Park, S. H., Gu, H., Roopenian, D., Chung, D. H., Kim, Y. S. and Lee, D. S., Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity. J. Immunol. 2005. 174: 2030-2036.
21. Campos, R. A., Szczepanik, M., Itakura, A., Akahira-Azuma, M., Sidobre, S., Kronenberg, M. and Askenase, P. W., Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate Tcell recruitment for elicitation of contact sensitivity. J. Exp. Med. 2003. 198: 1785-1796.
22. Gautam, S. C., Matriano, J. A., Chikkala, N. F., Edinger, M. G. and Tubbs, R. R., L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants. Cell. Immunol. 1991. 135: 27-41.
23. + Tcells in the immune response to the contact sensitizer trinitrophenyl. J. Immunol. 2004. 173: 3178-3185.
24. + T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism. J. Immunol. 2004. 172: 2286-2295.
25. Engeman, T. M., Gorbachev, A. V., Gladue, R. P., Heeger, P. S. and Fairchild, R. L., Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization. J. Immunol. 2000. 164: 5207-5214.
26. Jolles, S., Christensen, J., Holman, M., Klaus, G. B. and Ager, A., Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin. Clin. Exp. Immunol. 2002. 129: 519-526.
27. Sumida, T., Sakamoto, A., Murata, H., Makino, Y., Takahashi, H., Yoshida, S., Nishioka, K. et al., Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J. Exp. Med. 1995. 182: 1163-1168.
28. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 2001. 100: 144-148.
29. Grubor-Bauk, B., Simmons, A., Mayrhofer, G. and Speck, P. G., Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. J. Immunol. 2003. 170: 1430-1434.
30. Roberts, T. J., Lin, Y., Spence, P. M., Van Kaer, L. and Bratkiewicz, R. R., CD1d1-dependent control of the magnitude of an acute antiviral immune response. J. Immunol. 2004. 172: 3454-3461.
31. Naumov, Y. N., Babjat K. S., Gausling, R., Abraham, R., Exley, M. A., Koezuka, Y., Balk, S. B. et al., Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 2001. 98: 13838-13843.
32. Singh, A. K., Wilson, M. T., Hong, S., Olivares-Villagomez, D., Du, C., Stanic, A. K., Joyce, S. et al., Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 2001. 194: 1801-1811.
33. Chiba, A., Oki, S., Miyamoto, K., Hashimoto, H., Yamamura, T. and Miyake, S., Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum. 2004. 50: 305-313.
34. Hayakawa, Y., Takeda, K., Yagita, H., Kakuta, S., Iwakura, Y., Van Kaer, L., Saiki, I. and Okumura, K., Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Eur. J. Immunol. 2001. 31: 1720-1727.
35. Smyth, M. J., Crowe, N. Y., Pellicci, D. G., Kyparissoudis, K., Kelly, J. M., Takeda, K., Yagita, H. and Godfrey, D. L, Sequential production of interferon-gamina by NK1.1 (+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 2002. 99: 1259-1266.
36. + T cells independently of IL-12. J. Immunol. 2004. 173: 2443-2452.
37. + T cell development for contact hypersensitivity responses. J. Leukoc. Biol. 2005. 78: 725-735.
38. Chen, Y. G., Choisy-Rossi, C. M., Holl, T. M., Chapman, H. D., Besra, G. S., Porcelli, S. A., Shaffer, D. J. et al., Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J. Immunol. 2005. 174. 1196-1204.
39. Lee, P. T., Benlagha, K., Teyton, L. and Bendelac, A., Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 2002. 195: 637-641.
40. Ito, K., Karasawa, M., Kawano, T., Akasaka, T., Koseki, H., Akutsu, Y., Kondo, E. et al., Involvement of decidual Valpha14 NKT cells in abortion. Proc. Natl. Acad. Sci. USA 2000. 97. 740-744.
41. + NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 2004. 103: 383-389.
42. + T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions. J. Immunol. 2001. 166: 2323-2332.
43. + Th2 cells for contact hypersensitivity. J. Immunol. 1997. 159: 4217-4226.